These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9161629)

  • 1. Compatibility of ciprofloxacin lactate with sodium bicarbonate during simulated Y-site administration.
    Gilbert DL; Trissel LA; Martinez JF
    Am J Health Syst Pharm; 1997 May; 54(10):1193-5. PubMed ID: 9161629
    [No Abstract]   [Full Text] [Related]  

  • 2. Ciprofloxacin and sodium phosphates not compatible during actual Y-site injection.
    Benjamin BE
    Am J Health Syst Pharm; 1996 Aug; 53(15):1850-1. PubMed ID: 8842319
    [No Abstract]   [Full Text] [Related]  

  • 3. Stability and compatibility of admixtures of intravenous ciprofloxacin and selected drugs.
    Elmore RL; Contois ME; Kelly J; Noe A; Poirier A
    Clin Ther; 1996; 18(2):246-55. PubMed ID: 8733985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Everything in a compatibility study is important.
    Trissel LA
    Am J Health Syst Pharm; 1996 Dec; 53(24):2990. PubMed ID: 8974165
    [No Abstract]   [Full Text] [Related]  

  • 5. Compatibility of mannitol and sodium bicarbonate in injectable fluids.
    Matuschka PR; Smith WR; Vissing RS
    Am J Health Syst Pharm; 1995 Feb; 52(3):320-1. PubMed ID: 7749963
    [No Abstract]   [Full Text] [Related]  

  • 6. Visual compatibility of ciprofloxacin lactate with five broad-spectrum antimicrobial agents during simulated Y-site injection.
    Tucker DR; Sieradzan R
    Am J Hosp Pharm; 1988 Sep; 45(9):1910-1. PubMed ID: 3228127
    [No Abstract]   [Full Text] [Related]  

  • 7. Ciprofloxacin-ampicillin sulbactam incompatibility.
    Melonakos TK
    Ann Pharmacother; 1996 Jan; 30(1):87. PubMed ID: 8773177
    [No Abstract]   [Full Text] [Related]  

  • 8. Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection.
    Trissel LA; Parks NP; Santiago NM
    Am J Hosp Pharm; 1991 Oct; 48(10):2186-9. PubMed ID: 1781478
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential scanning calorimetry to investigate the compatibility of ciprofloxacin hydrochloride with excipients.
    Fathy M; Hassan MA; Mohamed FA
    Pharmazie; 2002 Dec; 57(12):825-8. PubMed ID: 12561245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical and chemical compatibility of intravenous ciprofloxacin with other drugs.
    Jim LK
    Ann Pharmacother; 1993 Jun; 27(6):704-7. PubMed ID: 8329786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More on compatibility of mannitol and sodium bicarbonate in injectable fluids.
    Matuschka PR; Hill LJ; Canada CA
    Am J Health Syst Pharm; 1996 Nov; 53(21):2639. PubMed ID: 8913398
    [No Abstract]   [Full Text] [Related]  

  • 12. Visual compatibility of ciprofloxacin with selected components of total parenteral nutrient solutions during simulated Y-site injection.
    Percy LA; Rho JP
    Am J Hosp Pharm; 1993 Apr; 50(4):715-6. PubMed ID: 8470693
    [No Abstract]   [Full Text] [Related]  

  • 13. Incompatibility of amiodarone hydrochloride and sodium bicarbonate injections.
    Korth-Bradley JM; Ludwig S
    Am J Health Syst Pharm; 1995 Oct; 52(20):2340. PubMed ID: 8564596
    [No Abstract]   [Full Text] [Related]  

  • 14. Compatibility of linezolid injection with intravenous administration sets.
    Zhang Y; Trissel LA
    J Am Pharm Assoc (Wash); 2001; 41(2):285-6. PubMed ID: 11297339
    [No Abstract]   [Full Text] [Related]  

  • 15. Compatibility of commonly used bone marrow transplant drugs during Y-site delivery.
    Najari Z; Rusho WJ
    Am J Health Syst Pharm; 1997 Jan; 54(2):181-4. PubMed ID: 9117807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
    Trissel LA; Williams KY; Gilbert DL
    J Am Pharm Assoc (Wash); 2000; 40(4):515-9. PubMed ID: 10932461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compatibility of filgrastim with selected antimicrobial drugs during simulated Y-site administration.
    Hall PD; Yui D; Lyons S; Bosso JA
    Am J Health Syst Pharm; 1997 Jan; 54(2):185-9. PubMed ID: 9117808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compatibility of alatrofloxacin mesylate with commonly used drugs during Y-site delivery.
    Voytilla KL; Rusho WJ; Tyler LS
    Am J Health Syst Pharm; 2000 Aug; 57(15):1437-9. PubMed ID: 10938984
    [No Abstract]   [Full Text] [Related]  

  • 19. Visual compatibility of sargramostim with selected antineoplastic agents, anti-infectives, or other drugs during simulated Y-site injection.
    Trissel LA; Bready BB; Kwan JW; Santiago NM
    Am J Hosp Pharm; 1992 Feb; 49(2):402-6. PubMed ID: 1554007
    [No Abstract]   [Full Text] [Related]  

  • 20. The compatibility of a low concentration of hydrocortisone sodium succinate with selected drugs during a simulated Y-site administration.
    Semark AJ; Venkatesh K; McWhinney BC; Pretorius C; Roberts JA; Cohen J; Venkatesh B
    Crit Care Resusc; 2013 Mar; 15(1):63-6. PubMed ID: 23432505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.